0001720725-19-000002.txt : 20190227 0001720725-19-000002.hdr.sgml : 20190227 20190227143402 ACCESSION NUMBER: 0001720725-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190227 DATE AS OF CHANGE: 20190227 EFFECTIVENESS DATE: 20190227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oyster Point Pharma, Inc. CENTRAL INDEX KEY: 0001720725 IRS NUMBER: 811030955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333703 FILM NUMBER: 19637078 BUSINESS ADDRESS: STREET 1: 700 ALEXANDER PARK DRIVE STREET 2: SUITE 301 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 382-9032 MAIL ADDRESS: STREET 1: 700 ALEXANDER PARK DRIVE STREET 2: SUITE 301 CITY: PRINCETON STATE: NJ ZIP: 08540 D 1 primary_doc.xml X0708 D LIVE 0001720725 Oyster Point Pharma, Inc. 700 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ NEW JERSEY 08540 (609) 382-9032 DELAWARE None None Corporation true 2015 William J Link c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Director Ali Behbahani c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Director D. Michael Ackermann c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Director Mark A. Murray c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Executive Officer Director Jeffrey Nau c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Executive Officer Director Benjamin Tsai c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Director Clare Ozawa c/o Oyster Point Pharma, Inc. 700 Alexander Park Drive, Suite 301 Princeton NJ NEW JERSEY 08540 Director Pharmaceuticals Decline to Disclose 06b false 2019-02-15 false true false 0 92999999 84999985 8000014 false 7 0 0 0 false Oyster Point Pharma, Inc. /s/Jeffrey Nau Jeffrey Nau President and Chief Executive Officer 2019-02-26